Matthew Patterson
2018
In 2018, Matthew Patterson earned a total compensation of $780.5K as Chief Executive Officer at Audentes Therapeutics, a 89% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $238,480 |
|---|---|
| Salary | $542,000 |
| Total | $780,480 |
Patterson received $542K in salary, accounting for 69% of the total pay in 2018.
Patterson also received $238.5K in non-equity incentive plan.
Rankings
In 2018, Matthew Patterson's compensation ranked 10,296th out of 14,244 executives tracked by ExecPay. In other words, Patterson earned more than 27.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,296 out of 14,244 | 28th |
Division Manufacturing | 4,152 out of 5,765 | 28th |
Major group Chemicals And Allied Products | 1,562 out of 2,128 | 27th |
Industry group Drugs | 1,318 out of 1,817 | 28th |
Industry Biological Products, Except Diagnostic Substances | 255 out of 339 | 25th |
Source: SEC filing on April 26, 2019.
Patterson's colleagues
We found four more compensation records of executives who worked with Matthew Patterson at Audentes Therapeutics in 2018.